In a world first move, Sweden has introduced legislation allowing grandparents to receive paid parental leave while caring for their grandchildren.  The new law, which took effect last year, enables grandparents to step in and get paid for looking after their grandchildren for up to 3 months of the child’s first year.

The goal is to provide Swedish families with greater flexibility and support in managing childcare, particularly during the early stages of a child’s life.

Sweden was the first country in the world to implement paid parental leave for fathers, a milestone achieved 50 years ago.

Read more here.

A groundbreaking study has explored the potential of using autologous cord blood stem cells for treating refractory Crohn’s Disease – a condition where standard treatments fail to manage symptoms. The trial evaluated the long-term effects of using a patient’s own stored cord blood stem cells.  The results were highly promising, with a significant percentage of patients showing improvement and a notable reduction in symptoms and many patients achieving remission.

Read the full study here.

Umbilical cord blood mesenchymal stem cell transplantation as a novel method for repairing knee joint cartilage has shown promising results in clinical settings, providing an effective treatment option for patients with these issues. A new review of the clinical research into the use of umbilical cord blood stem cells for knee articular cartilage repair has shown broad potential in regenerative medicine.

The long-term effects of using a patient’s own stored cord blood stem cells were evaluated – and showed highly promising results. A significant percentage of patients showed improvement and a notable reduction in symptoms and many patients achieved remission.

While further exploration and clinical trials are needed to strengthen the ongoing research, researchers look forward to more innovative breakthroughs – bringing better treatment outcomes and quality of life to patients.

Read more here.

Australian researchers have discovered a potential new lifeline for the tiniest and most vulnerable newborns. Scientists at Monash Children’s Hospital have successfully collected and reinfused umbilical cord blood cells in extremely premature babies, offering a glimmer of hope for preventing brain injuries.

This pioneering research has successfully demonstrated the feasibility of using a baby’s own cord blood stem cells as a potential treatment for extremely premature infants (born before 28 weeks). The trial demonstrated that umbilical cord blood stem cell collection and reinfusion is feasible and also well-tolerated in these vulnerable babies. Premature babies are at a high risk of brain injuries that can lead to lifelong challenges like cerebral palsy. By using their own cord blood stem cells, researchers believe they might be able to provide a natural ‘protective shield’ for these vulnerable infants’ developing brains.

Read more here.